ALLIANCE NEWS                                                  Nov. 10, 21014

Hamburg - Researchers at the Hamburg University Clinic (UKE) have begun the first tests on humans in Germany of an Ebola vaccine. The vaccine delivered by the World Health Organisation (WHO) is initially to be tested on 30 volunteers over the next six months, the clinic said Monday, noting that tests on animals had been successful.

If all the testing phases in Hamburg go successfully, then it is hoped that the vaccine can start to be employed by the fall of 2015, a UKE spokeswoman said.

It is hoped that the vaccine "rVSV-ZEBOV," (developed in Canada) can provide protection after just a single dose. Additionally, it might prove to be effective if applied immediately after an Ebola infection starts.

Parallel to the UKE research, scientists from the University Clinic of Tuebingen are to start testing the vaccine on volunteers in Gabon. Other studies are underway in the US and are soon to get started up in Switzerland, Hamburg doctors said.

http://www.lse.co.uk/AllNews.asp?code=vdoolxoa&headline=First_Test_Of_Ebola_Vaccine_On_Humans_In_Germany_Gets_Underway

UPDATE 

New York doctor cleared of Ebola, which means there are no known Ebola cases in the U.S.

WASHINGTON POST                                                                     Nov. 10, 2014

By Mark Herman

The doctor who contracted Ebola in West Africa before returning to New York City has been declared free of the virus, hospital officials announced Monday. This news means that 41 days after the first Ebola diagnosis in the United States, there are no known cases of the virus in the country.

Craig Spencer, 33, who had been treating Ebola patients in Guinea, was diagnosed with Ebola on Oct. 23. Bellevue Hospital Center in New York City, where Spencer was being treated, confirmed in a statement Monday that he “has been declared free of the virus.” Spencer will be discharged on Tuesday, according to the hospital.

See complete story

ASSOCIATED PRESS                                                                                               Nov. 10, 2014
By Wade Williams

JENEWONDE, Liberia --The community of Jenewonde has become a new hotspot for the Ebola outbreak in Liberia. With cases on the decline in the capital, officials must now turn their attention to hard-to-reach places where the disease is flaring.

In this photo, a woman reacts, rear, as Health Care workers load the body of a family member suspected of dying from Ebola, onto the back of a truck in Jene-Wonde, Liberia. A schoolteacher brought his sick daughter from Liberia’s capital to this small town of 300 people. Soon he was dead along with his entire family, all buried in the forest nearby. (AP Photo/ Wade Williams)

Jenewonde, in Grand Cape Mount County near the border with Sierra Leone, has reportedly lost about 10 percent of its population to Ebola since late September. Markets and farms nearby have been abandoned.

Ebola is also hitting the town of Gorzohn in Rivercess County, which lies on Liberia's central coast, said Assistant Health Minister Tolbert Nyenswah, who heads Liberia's Ebola response.

Liberia:  MSN warns that gains must not be underminded. Meanwhile U.S opens the first of its 17 treatment centers.  

(Two stories, scroll down)

 DOCTORS WITHOUT BORDERS                                                     Nov. 10, 2014

Monrovia – While the number of new Ebola cases reported in Liberia has declined in recent weeks, the outbreak is far from over and new hotspots continue to emerge across the country, the international medical humanitarian organization Médecins Sans Frontières (MSF) said today, warning that the international aid response must rapidly adapt to this new phase of the epidemic, or risk undermining progress made against Ebola.

Unlike in neighbouring Guinea and Sierra Leone, where cases are on the rise, MSF teams in Liberia are witnessing a decline in the number of Ebola patients admitted to case management centres (CMCs) for the first time since the beginning of the Ebola epidemic.... Case numbers could again rise, as they have in Guinea, where, following two significant dips in admissions to MSF facilities, patient numbers are again increasing.